MedPath

Armaceutica, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
https://armaceutica.com/

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Phase 2
Conditions
Acute Myeloid Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)
Interventions
First Posted Date
2022-03-22
Last Posted Date
2022-11-29
Lead Sponsor
Armaceutica, Inc.
Target Recruit Count
200
Registration Number
NCT05291390
Locations
🇸🇳

Dalal Jamm Hospital, Guediawaye GOL SUD, Dakar, Senegal

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.